JP2005506334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506334A5 JP2005506334A5 JP2003532491A JP2003532491A JP2005506334A5 JP 2005506334 A5 JP2005506334 A5 JP 2005506334A5 JP 2003532491 A JP2003532491 A JP 2003532491A JP 2003532491 A JP2003532491 A JP 2003532491A JP 2005506334 A5 JP2005506334 A5 JP 2005506334A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- composition according
- conh
- thiophene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32697601P | 2001-10-04 | 2001-10-04 | |
| PCT/US2002/031902 WO2003029242A1 (en) | 2001-10-04 | 2002-10-04 | NF-λB INHIBITORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506334A JP2005506334A (ja) | 2005-03-03 |
| JP2005506334A5 true JP2005506334A5 (enExample) | 2006-01-05 |
Family
ID=23274589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003532491A Pending JP2005506334A (ja) | 2001-10-04 | 2002-10-04 | ＮＦ−κＢ阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7166639B2 (enExample) |
| EP (1) | EP1448545B1 (enExample) |
| JP (1) | JP2005506334A (enExample) |
| AT (1) | ATE414697T1 (enExample) |
| DE (1) | DE60229975D1 (enExample) |
| ES (1) | ES2315430T3 (enExample) |
| WO (1) | WO2003029242A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003154D0 (en) * | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| EP2363396A1 (en) * | 2001-06-11 | 2011-09-07 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| TW200403991A (en) | 2002-04-11 | 2004-03-16 | Smithkline Beecham Corp | NF-κb inhibitors |
| US7375131B2 (en) * | 2002-06-06 | 2008-05-20 | Smithklinebeecham Corp. | NF-κB inhibitors |
| SE0202279D0 (sv) * | 2002-07-19 | 2002-07-19 | Astrazeneca Ab | Novel comppounds |
| SE0202280D0 (sv) * | 2002-07-19 | 2002-07-19 | Astrazeneca Ab | Novel compounds |
| EP1556053A4 (en) | 2002-10-31 | 2006-04-19 | Amgen Inc | ANTI-INFLAMMATORY AGENTS |
| WO2004053087A2 (en) * | 2002-12-06 | 2004-06-24 | Smithkline Beecham Corporation | Nf-κb inhibitors |
| DE60332482D1 (de) | 2002-12-10 | 2010-06-17 | Virochem Pharma Inc | Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen |
| SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| ES2314443T3 (es) | 2003-08-15 | 2009-03-16 | Astrazeneca Ab | Tiofenos sustituidos y sus usos. |
| WO2005056562A1 (en) * | 2003-12-05 | 2005-06-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors |
| JP2007517843A (ja) * | 2004-01-05 | 2007-07-05 | アストラゼネカ アクチボラグ | Ｃｈｋ１阻害剤であるチオフェン誘導体 |
| GB0402809D0 (en) * | 2004-02-09 | 2004-03-10 | Glaxo Group Ltd | Chemical compounds |
| TW200609237A (en) * | 2004-04-12 | 2006-03-16 | Sankyo Co | Thienopyridine derivatives |
| JP5117374B2 (ja) | 2005-03-29 | 2013-01-16 | イコス・コーポレイション | Ｃｈｋ１阻害に有用なヘテロアリール尿素誘導体 |
| JP5030947B2 (ja) * | 2005-05-13 | 2012-09-19 | ヴァイロケム・ファーマ・インコーポレーテッド | フラビウイルス感染の治療及び予防のための化合物及び方法 |
| WO2007097981A2 (en) | 2006-02-16 | 2007-08-30 | Millennium Pharmaceuticals, Inc. | Alpha carbolines and uses thereof |
| SG176488A1 (en) * | 2006-11-15 | 2011-12-29 | Virochem Pharma Inc | Thiophene analogues for the treatment or prevention of flavivirus infections |
| WO2009132050A2 (en) | 2008-04-21 | 2009-10-29 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| JP2010006717A (ja) * | 2008-06-24 | 2010-01-14 | Kyorin Pharmaceut Co Ltd | ジヒドロチエノ［２，３−ｅ］インダゾール化合物 |
| EP2366699B1 (en) | 2008-10-02 | 2013-08-07 | Asahi Kasei Pharma Corporation | 8-substituted isoquinoline derivative and use thereof |
| US20100135984A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
| US20100136094A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100136096A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| US20100135983A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
| US20100137246A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Anti-inflammatory compositions and methods |
| US20100135908A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Delivery devices for modulating inflammation |
| US20100136095A1 (en) * | 2008-12-02 | 2010-06-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems for modulating inflammation |
| WO2011077502A1 (ja) * | 2009-12-21 | 2011-06-30 | 杏林製薬株式会社 | ジヒドロチエノ［２，３－ｅ］インダゾール化合物 |
| EP2520292A1 (en) | 2011-05-06 | 2012-11-07 | Helmholtz-Zentrum für Infektionsforschung GmbH | Use of spirangiens for the treatment or prevention of IL-8 or IL-6 mediated disorders |
| EP2898102A4 (en) | 2012-09-20 | 2016-05-18 | Univ Emory | CLASSIFIERS OF NF-KB-PFADAKTIVIERUNG AND DEVICES AND METHODS OF USE THEREOF |
| EP3478269A4 (en) | 2016-06-29 | 2020-04-08 | Otonomy, Inc. | OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES |
| WO2019012159A1 (en) | 2017-07-14 | 2019-01-17 | Protea Biopharma N.V. | METHODS AND MEANS FOR DIAGNOSING AND / OR TREATING A FATIGUE-ASSOCIATED DISEASE |
| ES3011633T3 (en) | 2017-08-31 | 2025-04-07 | Ahammune Biosciences Private Ltd | Thiophene compounds, process for synthesis and use thereof for the treatment of autoimmune disorders |
| CN115161289B (zh) * | 2022-03-14 | 2023-12-05 | 东南大学 | 一种用于炎症性疾病治疗的重组腺相关病毒及其构建方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1468012A (en) * | 1973-08-09 | 1977-03-23 | Beecham Group Ltd | 2-amino-3-carboxy-thiophene derivatives |
| DE4039734A1 (de) | 1990-12-13 | 1992-06-17 | Basf Ag | Substituierte 2-aminothiophene enthaltende herbizide mittel |
| US6274590B1 (en) * | 1993-01-15 | 2001-08-14 | G. D. Searle & Co. | Method of treating skin related conditions |
| DE19642451A1 (de) * | 1996-10-15 | 1998-04-16 | Merck Patent Gmbh | Aminothiophencarbonsäureamide |
| CZ302691B6 (cs) * | 1998-07-08 | 2011-09-07 | Sanofi - Aventis Deutschland GmbH | N-Arylamidová sloucenina, zpusob její prípravy, farmaceutický prostredek tuto slouceninu obsahující, tato sloucenina pro použití jako aktivátor a pro použití k terapii nebo profylaxi |
| GB0003154D0 (en) * | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| US6414013B1 (en) * | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| AU2002211663A1 (en) | 2000-10-12 | 2002-04-22 | Smith Kline Beecham Corporation | Nf-$g(k)b inhibitors |
| US6713638B2 (en) * | 2001-05-18 | 2004-03-30 | Joel M. Linden | 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors |
| EP2363396A1 (en) * | 2001-06-11 | 2011-09-07 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| SE0102617D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| US6835745B2 (en) * | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
| US7084178B2 (en) * | 2003-11-26 | 2006-08-01 | Bristol-Myers Squibb Company | Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives |
-
2002
- 2002-10-04 US US10/491,710 patent/US7166639B2/en not_active Expired - Fee Related
- 2002-10-04 WO PCT/US2002/031902 patent/WO2003029242A1/en not_active Ceased
- 2002-10-04 AT AT02800491T patent/ATE414697T1/de not_active IP Right Cessation
- 2002-10-04 EP EP02800491A patent/EP1448545B1/en not_active Expired - Lifetime
- 2002-10-04 ES ES02800491T patent/ES2315430T3/es not_active Expired - Lifetime
- 2002-10-04 JP JP2003532491A patent/JP2005506334A/ja active Pending
- 2002-10-04 DE DE60229975T patent/DE60229975D1/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006510676A5 (enExample) | ||
| JP2019131569A5 (enExample) | ||
| JP2019513804A5 (enExample) | ||
| JP2007522142A5 (enExample) | ||
| JP2006182786A5 (enExample) | ||
| JP2008504363A5 (enExample) | ||
| JP2017514839A5 (enExample) | ||
| JP2018150331A5 (enExample) | ||
| ES2407807T3 (es) | Derivados de tiazolilo 2-amino-4,5-trisustituidos y su uso frente a enfermedades autoinmunitarias | |
| JP2006514626A5 (enExample) | ||
| CN110785173B (zh) | 氨基烷基苯并硫氮杂卓衍生物的用途 | |
| JP2012255002A5 (enExample) | ||
| JP2008512490A5 (enExample) | ||
| JP2010526814A5 (enExample) | ||
| HRP20240157T1 (hr) | Deuterirani derivati lanifibranora | |
| JP2005501012A5 (enExample) | ||
| JP2005529155A5 (enExample) | ||
| IL175716A (en) | 2- (4-Bromo- or 4-Methyl-Phenylamino) -6-Oxo-1,6-Dihydropyridines and their use in drug preparation | |
| RU2003105885A (ru) | Ингибиторы клеточной адгезии, опосредованной альфа 4-интегринами | |
| JP2007516983A5 (enExample) | ||
| JP2005508955A5 (enExample) | ||
| KR20100022998A (ko) | ３（이미다졸릴）피라졸로〔３，４ｂ〕피리딘 | |
| JP2022527401A5 (enExample) | ||
| JP2007507474A5 (enExample) | ||
| JP2005528386A5 (enExample) |